Literature DB >> 19098932

The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

Sheng-Qiang Yu1, Kuo-Pao Lai, Shu-Jie Xia, Hong-Chiang Chang, Chawnshang Chang, Shuyuan Yeh.   

Abstract

The androgen receptor (AR) plays an important role in the development and progression of prostate cancer (PCa). Androgen deprivation therapy is initially effective in blocking tumor growth, but it eventually leads to the hormone-refractory state. The detailed mechanisms of the conversion from androgen dependence to androgen independence remain unclear. Several PCa cell lines were established to study the role of AR in PCa, but the results were often inconsistent or contrasting in different cell lines, or in the same cell line grown under different conditions. The cellular and molecular alteration of epithelial cells and their microenvironments are complicated, and it is difficult to use a single cell line to address this important issue and also to study the pathophysiological effects of AR. In this paper, we summarize the different effects of AR on multiple cell lines and show the disadvantages of using a single human PCa cell line to study AR effects on PCa. We also discuss the advantages of widely used epithelium-stroma co-culture systems, xenograft mouse models, and genetically engineered PCa mouse models. The combination of in vitro cell line studies and in vivo mouse models might lead to more credible results and better strategies for the study of AR roles in PCa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098932      PMCID: PMC3735204          DOI: 10.1038/aja.2008.44

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  87 in total

Review 1.  Hormonal and stromal regulation of normal and neoplastic prostatic growth.

Authors:  W A Ricke; Y Wang; T Kurita; S W Hayward; G R Cunha
Journal:  Prog Mol Subcell Biol       Date:  2005

Review 2.  Regulation of prostatic growth and function by peptide growth factors.

Authors:  Z Culig; A Hobisch; M V Cronauer; C Radmayr; A Hittmair; J Zhang; M Thurnher; G Bartsch; H Klocker
Journal:  Prostate       Date:  1996-06       Impact factor: 4.104

Review 3.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

4.  Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.

Authors:  H K Lin; S Yeh; H Y Kang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  The LNCaP cell line--a new model for studies on human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; T M Chu; Z L Wajsman; M Friedman; L Papsidero; U Kim; L S Chai; S Kakati; S K Arya; A A Sandberg
Journal:  Prog Clin Biol Res       Date:  1980

6.  Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

Authors:  K A Klein; R E Reiter; J Redula; H Moradi; X L Zhu; A R Brothman; D J Lamb; M Marcelli; A Belldegrun; O N Witte; C L Sawyers
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

7.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

Review 8.  Chromosomal deletions and tumor suppressor genes in prostate cancer.

Authors:  J T Dong
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

9.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Authors:  W D Tilley; G Buchanan; T E Hickey; J M Bentel
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

10.  Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival.

Authors:  Qing Yang; Kar-Ming Fung; Wanda V Day; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Cancer Cell Int       Date:  2005-04-06       Impact factor: 5.722

View more
  11 in total

1.  The androgen receptor transcriptional program in castration-resistant prostate cancer: cell lines vs. tissue samples.

Authors:  Jeffrey E Roth; Cody J Peer; Douglas K Price; William D Figg
Journal:  Cancer Biol Ther       Date:  2013-11-19       Impact factor: 4.742

Review 2.  Androgen receptor coactivators that inhibit prostate cancer growth.

Authors:  Garrett Daniels; Ruchi Jha; Ying Shen; Susan K Logan; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2014-04-05

3.  [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

Authors:  M Saar; J Kamradt; V Jung; M Stöckle; G Unteregger
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

4.  Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.

Authors:  Shengqiang Yu; Shujie Xia; Diandong Yang; Ke Wang; Shuyuan Yeh; Zhenli Gao; Chawnshang Chang
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

5.  TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.

Authors:  Garrett Daniels; Yirong Li; Lan Lin Gellert; Albert Zhou; Jonathan Melamed; Xinyu Wu; Xinming Zhang; David Zhang; Daniel Meruelo; Susan K Logan; Ross Basch; Peng Lee
Journal:  Endocr Relat Cancer       Date:  2014-01-16       Impact factor: 5.678

6.  NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.

Authors:  Hsin-Hsiung Chen; Ping Fan; Szu-Wei Chang; Yeou-Ping Tsao; Hsiang-Po Huang; Show-Li Chen
Journal:  Oncotarget       Date:  2017-03-28

7.  Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.

Authors:  Henrique B da Silva; Eduardo P Amaral; Eduardo L Nolasco; Nathalia C de Victo; Rodrigo Atique; Carina C Jank; Valesca Anschau; Luiz F Zerbini; Ricardo G Correa
Journal:  Prostate Cancer       Date:  2013-04-29

8.  Registered report: the androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.

Authors:  Denise Chronscinski; Srujana Cherukeri; Fraser Tan; Nicole Perfito; Joelle Lomax; Elizabeth Iorns
Journal:  PeerJ       Date:  2015-09-15       Impact factor: 2.984

9.  Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.

Authors:  Inge Seim; Penny L Jeffery; Laura de Amorim; Carina M Walpole; Jenny Fung; Eliza J Whiteside; Rohan Lourie; Adrian C Herington; Lisa K Chopin
Journal:  Reprod Biol Endocrinol       Date:  2013-07-23       Impact factor: 5.211

10.  Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.

Authors:  Helen M Palethorpe; Paul A Drew; Eric Smith
Journal:  Dig Dis Sci       Date:  2017-10-20       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.